Can-Fite BioPharma American Depositary Shares
CANF
4 hedge funds and large institutions have $2.18M invested in Can-Fite BioPharma American Depositary Shares in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
423% more capital invested
Capital invested by funds: $416K → $2.18M (+$1.76M)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more funds holding
Funds holding: 2 → 4 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$10K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$33K |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ES
1
Equitec Specialists
Chicago,
Illinois
| $1.75M | +$1.67M | +167 | New |
|
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $409K | – | – | – |
|
|
3
Morgan Stanley
New York
| $5K | +$10K | +1 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $5K | +$10K | +1 | New |
|
5
Citigroup
New York
| $2K | – | – | – |
|
6
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
|
BRWA
7
B. Riley Wealth Advisors
Boca Raton,
Florida
| $4 | – | – | – |
|
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$33K | -3 | Closed |
|
|
9
Ameriprise
Minneapolis,
Minnesota
| – | -$1K | – | – |
|
CANF Hedge Fund Activity: Q4 2014 in Review
4 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q4 2014, worth a combined $2.18M — up 423% from $416K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CANF positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $10K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $33K sold.
- 4 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q4 2014, up from 2 in Q3 2014.
- Funds reported $2.18M of Can-Fite BioPharma American Depositary Shares stock for Q4 2014, up 423% quarter-over-quarter.
- 3 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q4 2014 and 1 closed out, a net change of +2 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q4 2014 was Morgan Stanley, an estimated $10K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q4 2014 was Susquehanna International Group, an estimated $33K sold.
Based on aggregated 13F filings for Q4 2014.